InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Jacob A Orville, a General Manager, Screening, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 16 open-market SEC Form 4 transactions: 0 purchases worth $0 and 16 sales worth $2.7M, reported from Feb 15, 22 to Nov 19, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 19, 25 | EXASEXACT SCIENCES CORP | SELL | 5.0K | $75.00 | $375K |
| May 1, 24 | EXASEXACT SCIENCES CORP | SELL | 102 | $60.15 | $6K |
| Mar 1, 24 | EXASEXACT SCIENCES CORP | SELL | 2.2K | $59.32 | $128K |
| Feb 27, 24 | EXASEXACT SCIENCES CORP | SELL | 1.9K | $56.89 | $107K |
| Feb 22, 24 | EXASEXACT SCIENCES CORP | SELL | 1.0K | $59.78 | $61K |
| Feb 21, 24 | EXASEXACT SCIENCES CORP | SELL | 1.1K | $61.50 | $66K |
| Feb 15, 24 | EXASEXACT SCIENCES CORP | SELL | 966 | $61.43 | $59K |
| May 10, 23 | EXASEXACT SCIENCES CORP | SELL | 5.0K | $80.00 | $400K |
| Mar 3, 23 | EXASEXACT SCIENCES CORP | SELL | 5.0K | $65.00 | $325K |
| Feb 28, 23 | EXASEXACT SCIENCES CORP | SELL | 5.0K | $61.12 | $300K |
| Feb 22, 23 | EXASEXACT SCIENCES CORP | SELL | 2.7K | $62.72 | $170K |
| Feb 15, 23 | EXASEXACT SCIENCES CORP | SELL | 954 | $69.59 | $66K |
| Feb 24, 22 | EXASEXACT SCIENCES CORP | SELL | 4.7K | $70.10 | $331K |
| Feb 23, 22 | EXASEXACT SCIENCES CORP | SELL | 1.1K | $69.05 | $78K |
| Feb 22, 22 | EXASEXACT SCIENCES CORP | SELL | 1.7K | $72.72 | $127K |
| Feb 15, 22 | EXASEXACT SCIENCES CORP | SELL | 940 | $79.55 | $75K |